Full Year 2018 Epigenomics AG Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Epigenomics AG conference call regarding the full year results 2018. (Operator Instructions) Let me now turn the floor over to your host, Mr. Frederic Hilke.
Thanks you very much, Sandra. Hello, and welcome to the conference call on the occasion of the 2018 full year financial results. My name is Frederic Hilke, I am the Investor Relations Manager at Epigenomics since the beginning of the year. With me here on the phone is the CEO of Epigenomics AG, Greg Hamilton. Before I hand over to him for the presentation, let me point out some of the usual legal information. The following presentation will contain expressly or implicitly certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Epigenomics AG to be materially different from any future results, performance or
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |